GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.98 $7.70 Thursday, 18th Apr 2024 FATE stock ended at $5.04. This is 4.36% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.33% from a day low at $4.98 to a day high of $5.35.
90 days $4.10 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2020-08-13 $34.40 $35.46 $34.20 $35.01 290 634
2020-08-12 $34.97 $35.19 $33.54 $34.11 1 169 055
2020-08-11 $35.87 $36.74 $34.61 $34.70 702 195
2020-08-10 $33.89 $36.60 $33.89 $36.00 786 456
2020-08-07 $33.57 $34.65 $33.20 $33.83 499 146
2020-08-06 $32.00 $36.00 $31.89 $33.42 915 180
2020-08-05 $33.07 $33.20 $32.47 $32.84 545 569
2020-08-04 $32.95 $33.08 $31.73 $32.62 383 891
2020-08-03 $31.45 $33.44 $31.37 $33.21 643 817
2020-07-31 $31.75 $32.06 $30.35 $31.27 774 875
2020-07-30 $30.44 $31.94 $30.44 $31.60 329 508
2020-07-29 $31.33 $31.45 $30.17 $30.78 677 008
2020-07-28 $33.00 $33.22 $31.14 $31.19 575 845
2020-07-27 $32.00 $33.52 $31.81 $33.25 561 635
2020-07-24 $32.00 $33.10 $31.26 $31.90 571 827
2020-07-23 $33.37 $33.81 $32.00 $32.52 492 376
2020-07-22 $33.67 $34.24 $33.37 $33.59 312 400
2020-07-21 $35.27 $35.35 $33.60 $33.83 444 000
2020-07-20 $34.10 $35.60 $33.89 $34.94 575 000
2020-07-17 $33.55 $34.64 $33.06 $34.40 451 900
2020-07-16 $34.55 $34.71 $33.16 $33.55 404 200
2020-07-15 $34.71 $35.34 $34.26 $34.87 740 000
2020-07-14 $33.21 $34.13 $32.68 $34.02 1 050 000
2020-07-13 $35.62 $36.07 $32.88 $33.21 774 000
2020-07-10 $36.49 $36.70 $35.14 $35.26 682 000
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT